MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): Benchmark Tetrazolium Salt for Colorimetric Cell Viability Assays

Executive Summary: MTT, a tetrazolium salt with CAS 298-93-1, is extensively used for in vitro assessment of cell viability and metabolic function via colorimetric assay. Its reduction by NADH-dependent mitochondrial oxidoreductases produces insoluble purple formazan, directly correlating with living cell number and metabolic activity (Zhang et al., 2020). MTT is cationic and membrane-permeable, facilitating direct intracellular access without transport intermediates. The compound is optimally soluble at ≥41.4 mg/mL in DMSO and ≥2.5 mg/mL in water (with ultrasonic assistance) (APExBIO product page). For reliable results, high-purity MTT (≥98%) from APExBIO is recommended, and solutions should be stored at -20°C for short-term use. The assay is strictly for research, not clinical diagnostics.

Biological Rationale

MTT is designed to quantify viable, metabolically active cells in vitro. Cellular metabolic activity is a hallmark of viability and proliferation. NADH-dependent oxidoreductases, predominantly located in mitochondria, mediate the reduction of MTT to formazan, providing a direct readout of cellular metabolic health (Zhang et al., 2020). This approach is fundamental in cancer research, drug screening, and apoptosis assays, where precise measurement of cell number and activity is critical (see Cellron.net: Benchmark Tetrazolium Salt for Cell Viability Assays). Unlike alternative cell viability assays, MTT uniquely combines sensitivity, convenience, and direct quantification of living cells.

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT enters viable cells due to its cationic, membrane-permeable nature. Inside the cell, NADH-dependent mitochondrial oxidoreductases catalyze the reduction of the yellow MTT to insoluble purple formazan crystals (Zhang et al., 2020). Extra-mitochondrial enzymes also contribute to this reaction. The resulting formazan accumulates intracellularly and is solubilized with DMSO or ethanol for quantification by absorbance (commonly at 570 nm). The reduction process is stoichiometric and correlates directly with the number of metabolically active, viable cells (see Annexin-v-pe.com: Unraveling Cellular Metabolism and Viability in Cancer Research - This article provides a mechanistic deep dive and highlights cancer-specific applications, while the present article offers a broader benchmark overview).

Evidence & Benchmarks

• MTT reduction is primarily mediated by NADH-dependent dehydrogenases located in mitochondria and cytosol, producing formazan in proportion to viable cell number (Zhang et al., 2020).
• MTT is soluble at ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, and ≥2.5 mg/mL in water (with ultrasonic assistance) (APExBIO product page).
• MTT assays can detect changes in cell proliferation and apoptosis in response to genetic manipulation, as shown in hepatocellular carcinoma cells treated with miR-519d (Zhang et al., Figure 3B, DOI).
• MTT outperforms second-generation tetrazolium salts (e.g., XTT, WST-1) in certain workflows due to its direct cell permeability and lack of requirement for intermediate electron carriers (see Annexin-v-cy3.com: Expanding the Frontiers - This article focuses on mechanistic differences; the current article emphasizes practical benchmarking and integration).
• High-purity (≥98%) MTT, as supplied by APExBIO, offers consistent performance and reproducibility in translational research applications (APExBIO product page).

Applications, Limits & Misconceptions

MTT is routinely applied in:

• In vitro cell proliferation and cytotoxicity assays.
• Metabolic activity measurements in primary cells and immortalized cell lines.
• Drug screening for cancer therapeutics and toxicology.
• Apoptosis and autophagy quantification in response to genetic or pharmacological interventions (Zhang et al., 2020).

However, some misconceptions and limitations exist regarding MTT's scope and interpretation.

Common Pitfalls or Misconceptions

• Non-viable cells do not reduce MTT: Only metabolically active, viable cells contribute to formazan formation. Dead cells do not participate in the reaction.
• Not suitable for in vivo use: MTT is for in vitro research only and is not approved for diagnostic or therapeutic use in humans or animals (APExBIO product page).
• Assay interference: Certain compounds (e.g., antioxidants or reducing agents) and culture media components can artificially influence MTT reduction and should be controlled or validated experimentally (see Peptide17.com: Optimizing Tetrazolium Salt Assays - This article provides troubleshooting insights; the current article aggregates benchmark data).
• Formazan solubilization step is critical: Incomplete solubilization of formazan leads to underestimation of cell viability.
• Late-stage apoptosis may yield ambiguous signals: Cells in late apoptosis may retain sufficient metabolic activity to reduce MTT, potentially leading to overestimation of viability.

Workflow Integration & Parameters

• Reagent Preparation: MTT is dissolved in DMSO (≥41.4 mg/mL), ethanol (≥18.63 mg/mL), or water (≥2.5 mg/mL with sonication). Filter sterilization is recommended for cell-based assays.
• Assay Protocol: Typical final concentration: 0.5 mg/mL per well. Incubation: 2–4 hours at 37°C in cell culture medium.
• Detection: Solubilize formazan with 100 μL DMSO or ethanol per well. Read absorbance at 570 nm (reference: 630–690 nm if available).
• Storage: Store powder at -20°C protected from light and moisture. Reconstituted solutions should be used within days for best results (APExBIO product page).
• Controls: Include blank wells (no cells) and negative controls (cells without treatment) for baseline correction.

Conclusion & Outlook

MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, B7777) remains a gold-standard in vitro cell viability and metabolic activity assay reagent. Its robust and reproducible chemistry, combined with APExBIO’s high-purity supply, underpins translational research in oncology, drug discovery, and cell biology. While alternative tetrazolium salts exist, MTT’s direct reduction and broad compatibility keep it central in workflows demanding high sensitivity and quantitative accuracy. Future advances may refine endpoint multiplexing, but MTT’s core utility is well-established and enduring.

To learn more or to order, visit the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) product page at APExBIO.